Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

243 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
Widmer M, Hanemann CO, Zajicek J. Widmer M, et al. Among authors: zajicek j. J Neurosci Res. 2008 Nov 1;86(14):3212-20. doi: 10.1002/jnr.21757. J Neurosci Res. 2008. PMID: 18615640
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Zeissler ML, Eastwood J, McCorry K, Hanemann CO, Zajicek JP, Carroll CB. Zeissler ML, et al. Among authors: zajicek jp. Oncotarget. 2016 Jul 19;7(29):46603-46614. doi: 10.18632/oncotarget.10314. Oncotarget. 2016. PMID: 27366949 Free PMC article.
Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease.
Carroll CB, Zeissler ML, Chadborn N, Gibson K, Williams G, Zajicek JP, Morrison KE, Hanemann CO. Carroll CB, et al. Among authors: zajicek jp. Neurochem Int. 2011 Aug;59(1):73-80. doi: 10.1016/j.neuint.2011.05.006. Epub 2011 Jun 6. Neurochem Int. 2011. PMID: 21672570
Therapeutic potential of cannabis in pain medicine.
Hosking RD, Zajicek JP. Hosking RD, et al. Among authors: zajicek jp. Br J Anaesth. 2008 Jul;101(1):59-68. doi: 10.1093/bja/aen119. Epub 2008 May 29. Br J Anaesth. 2008. PMID: 18515270 Review.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Carroll CB, Zeissler ML, Hanemann CO, Zajicek JP. Carroll CB, et al. Among authors: zajicek jp. Neuropathol Appl Neurobiol. 2012 Oct;38(6):535-47. doi: 10.1111/j.1365-2990.2011.01248.x. Neuropathol Appl Neurobiol. 2012. PMID: 22236282
Role of cannabinoids in multiple sclerosis.
Zajicek JP, Apostu VI. Zajicek JP, et al. CNS Drugs. 2011 Mar;25(3):187-201. doi: 10.2165/11539000-000000000-00000. CNS Drugs. 2011. PMID: 21323391 Review.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Cano MG, McManus D, Mallik S, Hobart J; CUPID investigator group. Zajicek J, et al. Lancet Neurol. 2013 Sep;12(9):857-865. doi: 10.1016/S1474-4422(13)70159-5. Epub 2013 Jul 13. Lancet Neurol. 2013. PMID: 23856559 Free PMC article. Review.
Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
Liu X, Carroll CB, Wang SY, Zajicek J, Bain PG. Liu X, et al. Among authors: zajicek j. J Neurosci Methods. 2005 May 15;144(1):47-52. doi: 10.1016/j.jneumeth.2004.10.005. Epub 2004 Nov 28. J Neurosci Methods. 2005. PMID: 15848238
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, Mallik S, Zajicek J. Ball S, et al. Among authors: zajicek j. Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120. Health Technol Assess. 2015. PMID: 25676540 Free PMC article. Clinical Trial.
Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis.
Zhang H, Hilton DA, Hanemann CO, Zajicek J. Zhang H, et al. Among authors: zajicek j. Brain Pathol. 2011 Sep;21(5):544-57. doi: 10.1111/j.1750-3639.2011.00477.x. Epub 2011 Feb 22. Brain Pathol. 2011. PMID: 21251115
243 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback